404 related articles for article (PubMed ID: 17565631)
21. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome.
Yki-Järvinen H
Lancet Diabetes Endocrinol; 2014 Nov; 2(11):901-10. PubMed ID: 24731669
[TBL] [Abstract][Full Text] [Related]
22. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis].
Choi SY; Kim D; Kang JH; Park MJ; Kim YS; Lim SH; Kim CH; Lee HS
Korean J Hepatol; 2008 Mar; 14(1):77-88. PubMed ID: 18367860
[TBL] [Abstract][Full Text] [Related]
23. Nonalcoholic fatty liver disease: defining a common problem.
Gasbarrini G; Vero V; Miele L; Forgione A; Hernandez AP; Greco AV; Gasbarrini A; Grieco A
Eur Rev Med Pharmacol Sci; 2005; 9(5):253-9. PubMed ID: 16231586
[TBL] [Abstract][Full Text] [Related]
24. Non-alcoholic fatty liver disease in diabetics--prevalence and predictive factors in a multiracial hospital clinic population in Malaysia.
Chan WK; Tan AT; Vethakkan SR; Tah PC; Vijayananthan A; Goh KL
J Gastroenterol Hepatol; 2013 Aug; 28(8):1375-83. PubMed ID: 23517307
[TBL] [Abstract][Full Text] [Related]
25. The epidemiology of nonalcoholic fatty liver disease in adults.
Clark JM
J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S5-10. PubMed ID: 16540768
[TBL] [Abstract][Full Text] [Related]
26. Nonalcoholic fatty liver disease - A multisystem disease?
Mikolasevic I; Milic S; Turk Wensveen T; Grgic I; Jakopcic I; Stimac D; Wensveen F; Orlic L
World J Gastroenterol; 2016 Nov; 22(43):9488-9505. PubMed ID: 27920470
[TBL] [Abstract][Full Text] [Related]
27. [Non-alcoholic fatty liver disease (NAFLD)].
Rau M; Weiss J; Geier A
Dtsch Med Wochenschr; 2015 Jul; 140(14):1051-5. PubMed ID: 26182253
[TBL] [Abstract][Full Text] [Related]
28. Nonalcoholic fatty liver disease in Asia: emerging perspectives.
Seto WK; Yuen MF
J Gastroenterol; 2017 Feb; 52(2):164-174. PubMed ID: 27637587
[TBL] [Abstract][Full Text] [Related]
29. Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome.
Moore JB
Proc Nutr Soc; 2010 May; 69(2):211-20. PubMed ID: 20158939
[TBL] [Abstract][Full Text] [Related]
30. New trends on obesity and NAFLD in Asia.
Fan JG; Kim SU; Wong VW
J Hepatol; 2017 Oct; 67(4):862-873. PubMed ID: 28642059
[TBL] [Abstract][Full Text] [Related]
31. Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?
Farrell GC
J Gastroenterol Hepatol; 2003 Feb; 18(2):124-38. PubMed ID: 12542595
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?
Almobarak AO; Barakat S; Suliman EA; Elmadhoun WM; Mohamed NA; Abobaker IO; Noor SK; Bushara SO; Ahmed MH
Arab J Gastroenterol; 2015 Jun; 16(2):54-8. PubMed ID: 26174761
[TBL] [Abstract][Full Text] [Related]
33. Ectopic fat, insulin resistance and non-alcoholic fatty liver disease.
Byrne CD
Proc Nutr Soc; 2013 Nov; 72(4):412-9. PubMed ID: 23668723
[TBL] [Abstract][Full Text] [Related]
34. [Non-alcoholic fatty liver disease--new view].
Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese.
Liu CJ
J Gastroenterol Hepatol; 2012 Oct; 27(10):1555-60. PubMed ID: 22741595
[TBL] [Abstract][Full Text] [Related]
36. The prevalence of nonalcoholic fatty liver disease in the Americas.
López-Velázquez JA; Silva-Vidal KV; Ponciano-Rodríguez G; Chávez-Tapia NC; Arrese M; Uribe M; Méndez-Sánchez N
Ann Hepatol; 2014; 13(2):166-78. PubMed ID: 24552858
[TBL] [Abstract][Full Text] [Related]
37. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Younossi ZM
Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of a fast emerging disease in the Asia-Pacific region: non-alcoholic fatty liver disease.
Wah-Kheong C; Khean-Lee G
Hepatol Int; 2013 Mar; 7(1):65-71. PubMed ID: 26201622
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World.
Sayiner M; Koenig A; Henry L; Younossi ZM
Clin Liver Dis; 2016 May; 20(2):205-14. PubMed ID: 27063264
[TBL] [Abstract][Full Text] [Related]
40. Characteristics and diagnosis of NAFLD/NASH.
Hashimoto E; Taniai M; Tokushige K
J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():64-70. PubMed ID: 24251707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]